Page 479 - Binder2
P. 479

(pg. 225) Nature. (2025).
               https://www.nature.com/articles/d41573-025-00017-x

               (pg. 69) Johnson & Johnson. (2024). Showcase of
               hematology portfolio at ASH Annual Meeting.
               https://innovativemedicine.jnj.com/us/johnson-johnson-to-
               showcase-strength-of-its-broad-hematology-portfolio-and-
               pipeline-at-the-2024-american-society-of-hematology-
               annual-meeting

               (pg. 69) Fierce Pharma. (n.d.). Darzalex Faspro approval
               update. https://www.fiercepharma.com/pharma/jj-touts-
               new-foundational-frontline-multiple-myeloma-treatment-
               darzalex-faspro-nabs

               (pg. 37) Association for Accessible Medicines. (2023). U.S.
               Generic & Biosimilar Medicines Savings Report.

               (pg. 88) Polinski, J. M., et al. (2021). Current Medical
               Research and Opinion.

               (pg. 119) Gastroenterology. (n.d.). COUR study.
               https://www.gastrojournal.org/article/S0016-
               5085(21)00521-7/fulltext

               (pg. 99) Mungfali. (n.d.). Types of T Cells and Their
               Functions [Graphic].https://mungfali.com/explore/Types-
               of-T-Cells-and-Their-Function


               (pg 180) Tschofen, M., Knopp, D., Hood, E., & Stöger, E.
               (2016). Plant molecular farming: Much more than
               medicines. Annual Review of Analytical Chemistry, 9, 271–
               294. https://doi.org/10.1146/annurev-anchem-071015-
               041706






                                          477
   474   475   476   477   478   479   480   481   482   483   484